Postmarket surveillance of natural health products in Canada: Clinical and federal regulatory perspectives

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 9, 2007, Pages 952-955

  Murty, Mano ^a  

^a HEALTH CANADA   (Canada)

Author keywords

Adverse reactions; Causality reviews; Clinical and regulation challenges; Natural health products; Postmarket surveillance; Risk communication; Safety issues

Indexed keywords

ESSENTIAL FATTY ACID; HOMEOPATHIC AGENT; MINERAL; PROBIOTIC AGENT; VITAMIN;

ALGA; BACTERIUM; CANADA; FUNGUS; HUMAN; NONHUMAN; ORGANIZATION; PLANT; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TRADITIONAL MEDICINE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BIOLOGICAL PRODUCTS; CANADA; DRUG INDUSTRY; HUMANS; LEGISLATION, DRUG; PRODUCT SURVEILLANCE, POSTMARKETING; RISK ASSESSMENT;

EID: 36549068168     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-085     Document Type: Review

References (23)

1. Adverse Reaction Reporting. 2007. Adverse Reaction Reporting (E-format). Health Canada Web site. Available from http://www.hc-sc.gc.ca/ahc-asc/media/ reaction/index_e.html [accessed 16/03/07].
2. Barnes, J. 2003. Pharmacovigilance of Herbal Medicines - A UK perspective. Drug Saf. 26: 829-851. doi:10.2165/00002018-200326120-00001.
3. Basch, E.M., Servoss, J.C., and Tedrow, U.B. 2005. Safety assurances for dietary supplements policy issues and new research paradigms. J. Herb. Pharmacother. 5: 3-15. doi:10.1300/J157v05n01_02.
4. Baseline NHP Survey Among Consumers. 2005. Final Report, March 2005. Health Canada Web site. Available from http://www.hc-sc.gc.ca/dhp-mps/pubs/ natur/eng_cons_survey_e.html [accessed 16 March 2007].
5. Bast, A., Chandler, R.F., Choy, P.C., Delmulle, L.M., Gruenwald, J., Halkes, S.B.A., et al. 2002. Botanical health products, positioning and requirements for effective and safe use. Environ. Toxicol. Pharmacol. 12: 195-211. doi:10.1016/S1382-6689(02) 00035-2.
6. Canadian Adverse Reaction Newsletter Publication. 2007. Canadian Adverse Reaction Newsletter. Health Canada Web site. Available from http://www.hc-sc.gc. ca/dhp-mps/medeff/bulletin/index_e.html [accessed 16 March 2007].
7. Compliance Policy for NHPs in Canada. 2006. Health Canada Web site. Available from http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/pol/compli- conform/complian-conform_pol_e.html [accessed 16 March 2007].
8. Drew, A.K., and Myers, S.P. 1997. Safety issues in herbal medicine: implications for the health professions. Med. J. Aust. 166: 538-541.
9. Dietary Supplement Health and Education Act. 1994. US Food and Drug Administration Web site. Available from http://www.fda. gov/opacom/laws/dshea. html [accessed 16 March 2007].
10. Guidance for Industry Communications. 2005. Health Canada Web site. Available from http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/guide-ld/ guid-dir_indust_hppc-cpsp_e.html [accessed 16 March 2007].
11. Guideline for Natural Health Product Licence Holders. 2003. To submit safety data and adverse reaction reports. Health Canada Web site. Available from http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/arr-dri_e.html#1 [accessed 16 March 2007].
12. Health Canada Advisory. 2002. Health Canada requests recall of certain products containing Ephedra / ephedrine. Health Canada Web site. Available from http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2002/2002_01_e.html [accessed 16 March 2007].
13. Health Canada Advisory. 2003. Health Canada Advisory: Health Canada advises consumers not to use or ingest the herb comfrey or health products that contain comfrey. Health Canada Web site. Available from http://www.hc-sc.gc.ca/ ahc-asc/media/advisories-avis/2003/2003_101_e.html [accessed 16 March 2007].
14. Health Sciences Authority Chinese Proprietary Medicines. 2003. Introduction to the Regulation of Health Products in Singapore: Control of Chinese Proprietary Medicines. Health Sciences Authority Web site. Available from http://www.hsa.gov.sg/html/business/cda_cpm_info.html [accessed 16 March 2007].
15. Health Sciences Authority Health Supplements. 2003. Introduction to the Regulation of Health Products in Singapore: Control of Health Supplements. Health Sciences Authority Web site. Available from http://www.hsa.gov.sg/html/ business/cda_supplement_overview.html [accessed 16 March 2007].
16. It's Your Health. 2006a. It's Your Health: Safe use of health products containing camphor and eucalyptus oils. Health Canada Web site. Available from http://www.hc-sc.gc.ca/iyh-vsv/ life-vie/camphor-camphre_e.html [accessed 16 March 2007].
17. It's Your Health. 2006b. It's Your Health: Safe use of natural health products. Health Canada Web site. Available from http://www.hc-sc.gc.ca/ iyh-vsv/med/nat-prod_e.html [accessed 16 March 2007].
18. It's Your Health Publication. 2007. About It's Your Health. Health Canada Web site. Available from http://www.hc-sc.gc.ca/iyh-vsv/index_e.html [accessed 16 March 2007].
19. Medeffect. 2007. Health Canada Web site. Available from http://www.hc-sc.gc.ca/dhp-mps/medeff/index_e.html [accessed 16 March 2007].
20. Marketed Health Products Directorate Release of Draft. 2003. (Step 2) ICH Guidance: Pharmacovigilance Planning (E2E). http://www.hc-sc.gc.ca/dhp-mps/ prodpharma/applic-demande/guide-ld/ ich/consultation/e2e_step2_etape2_e.html [accessed 16 March 2007].
21. Natural Health Products Regulations. 2004. About Natural Health Product Regulation in Canada. Health Canada Web site. Available from http://www.hc-sc.gc.ca/dhp-mps/prodnatur/about-apropos/index_e.html [accessed 16 March 2007].
22. Reporting Adverse Reactions for Naturopathic Doctors. 2006. Health Canada Web site. Available from http://www.hc-sc.gc.ca/dhp-mps/medeff/centre-learn- appren/nd-dn_ar-ei_module_e.html [accessed 16 March 2007].
23. Risk Communication Products. 2006. Health Canada Web site. Available from http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2006/fact-feuille_e.html [accessed 16 March 2007].